Basic science research explores the effects of impaired glycine metabolism in nonalcoholic fatty liver disease and how to potentially use glycine-based treatment to help people with NAFLD.
Liver Conditions & Procedures
A Michigan Medicine team looks into the prevalence of NAFLD in patients with heart failure with preserved ejection fraction.
A team of experts compared rates of cirrhosis, cardiovascular disease and metabolic abnormalities between patients with fatty liver disease who were of normal weight and overweight or obese.
An international team of researchers conducts a study that defines a simple, low-cost blood test that yields high-performing results in the elimination of hepatitis C.
A collaborative U-M team shows that liver injury is less likely to originate from popular cancer immunotherapy drug, pembrolizumab, than tumor progression.
U-M researchers identify a potential treatment for non-alcoholic fatty liver disease.